TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33512462

Group type: EXPERIMENTAL
Intervention: Palliative and hospice care integration for female veterans
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Retrospective chart reviews
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prospective study designs
Number of subjects: 19
Study: 32019855

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 341872

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341872
Study: 33971913

Group type: EXPERIMENTAL
Intervention: Text-based conversation aid
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Picture-based conversation aid
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both conversation aids
Number of subjects: 43
Study: 34217079

Group type: EXPERIMENTAL
Intervention: Glyphosate 7.2 g a.e. ha−1 in winter season
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyphosate 36.0 g a.e. ha−1 in winter season
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyphosate 1.8 g a.e. ha−1 in winter season
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyphosate 12 g a.e. ha−1 in wet season
Number of subjects: 0
Study: 33370164

Group type: EXPERIMENTAL
Intervention: Blended family-based childhood obesity management program (10 weeks of in-person and online support)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 32126989

Group type: EXPERIMENTAL
Intervention: Seasonal malaria chemoprevention (SMC) implemented in health sub-districts
Number of subjects: 6638

Group type: COMPARATOR
Intervention: Control group (no SMC)
Number of subjects: 6638
Study: 35383101

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 100
Study: 32739224

Group type: EXPERIMENTAL
Intervention: Foot reflexology (performed for one week, three times a week, 30 min before dressing change)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 66
Study: 35770127

Group type: EXPERIMENTAL
Intervention: Prehospital first aid nursing based on network information sharing platform
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine first aid nursing
Number of subjects: 78
Study: 33734452

Group type: EXPERIMENTAL
Intervention: THY1773 (10 mg/day to 110 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: THY1773 (TS-121 capsule)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: THY1773 (in phase 1 RO study using PET)
Number of subjects: 0
Study: 32772571

Group type: EXPERIMENTAL
Intervention: Oral Anticoagulation (OAC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Antiplatelet Therapy (APT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Device-related thrombosis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Spontaneous echocardiography contrast pre-LAAC
Number of subjects: 78
Study: 33588768

Group type: EXPERIMENTAL
Intervention: Assistive technology and telecare
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study: 34098040

Group type: EXPERIMENTAL
Intervention: Mobile health application (Zamplo) used for 24 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: EXCEL only control group
Number of subjects: 0
Study: 32888712

Group type: EXPERIMENTAL
Intervention: Side-to-side cavocavostomy
Number of subjects: 290

Group type: COMPARATOR
Intervention: Traditional piggyback implantation
Number of subjects: 290
Study: 2004897541

Group type: EXPERIMENTAL
Intervention: AR‐paretic arm training (augmented-reality-based training)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control period (only regular therapy)
Number of subjects: 19
Study: 35410548

Group type: EXPERIMENTAL
Intervention: Mental contrasting of a negative future with a positive reality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vicarious mental contrasting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative fantasizing
Number of subjects: 0
Study: 32108399

Group type: EXPERIMENTAL
Intervention: Group I - without any protective or monitoring dispositive, limiting RF applications to 30 W for 20 seconds at left atrium posterior wall (LAPW)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Group II - power and time of RF delivery, up to 50 W for 20 seconds at LAPW, limited by esophageal temperature monitoring
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Group III - applications of RF in LAPW with fixed power application of 50 W for 20 seconds during continuous esophageal cooling
Number of subjects: 45
Study: 35379593

Group type: EXPERIMENTAL
Intervention: COPe-support (digital psychoeducation and peer support)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Passive online information resource (control)
Number of subjects: 407
Study: 34538275

Group type: EXPERIMENTAL
Intervention: ACT-guided heparinization (100 IU/kg bolus of heparin with ACT measurements)
Number of subjects: 750

Group type: COMPARATOR
Intervention: 5000 IU of heparin (no ACT measurements)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: ACT-guided heparinization
Number of subjects: 750
Study: 36017827

Group type: EXPERIMENTAL
Intervention: RID-TDS (twice weekly)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Exelon® (once daily)
Number of subjects: 57
Study: 32595083

Group type: EXPERIMENTAL
Intervention: Family mealtime communication
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Single-parent household
Number of subjects: 280
Study: 32206785

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolyl-hydroxylase domain (PHD) inhibitors
Number of subjects: 0
Study: 33148203

Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Randomised controlled trial of first-line intravenous iron
Number of subjects: 484
Study: 35179521

Group type: EXPERIMENTAL
Intervention: 3D-printed orthoses
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Traditionally made orthoses
Number of subjects: 13

Group type: COMPARATOR
Intervention: No orthoses
Number of subjects: 13
Study: 33630638

Group type: EXPERIMENTAL
Intervention: Similar Age Same Gender (SASG) exercise program
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Similar Age Mixed Gender (SAMG) exercise program
Number of subjects: 483

Group type: COMPARATOR
Intervention: Standard Mixed Age Mixed Gender (MAMG) exercise program
Number of subjects: 483
Study: 35306340

Group type: EXPERIMENTAL
Intervention: Personalized assay targeting tumour‐informed mutations
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Universal panel of genes frequently mutated in colorectal cancer (CRC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low depth sequencing for copy number alterations (CNAs)
Number of subjects: 60
Study: 32065760

Group type: EXPERIMENTAL
Intervention: BNP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NT‐proBNP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NT‐proBNP to BNP ratio
Number of subjects: 0
Study: 33924598

Group type: EXPERIMENTAL
Intervention: B-E (Breakfast and Exercise)
Number of subjects: 82
Study: 32450733

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combination of propofol and desflurane
Number of subjects: 70

Group type: COMPARATOR
Intervention: Remifentanil infusion
Number of subjects: 70

Group type: COMPARATOR
Intervention: Bilateral vs unilateral surgery
Number of subjects: 70
Study: 34989797

Group type: EXPERIMENTAL
Intervention: ω‐3‐PL/FFA (4 g/d)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo (cornstarch)
Number of subjects: 520
Study: 33561968

Group type: EXPERIMENTAL
Intervention: Lacto-ovo-vegetarian diet (VD; 65 g/day protein)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Western-type diet (WD; 95 g/day protein)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mixed diet (MD; 65 g/day protein)
Number of subjects: 10
Study: 35255077

Group type: EXPERIMENTAL
Intervention: General Anesthesia
Number of subjects: 297

Group type: COMPARATOR
Intervention: Spinal Anesthesia
Number of subjects: 297
Study: 34105880

Group type: EXPERIMENTAL
Intervention: Tooth-borne RME appliance (hyrax)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tooth-bone-borne RME appliance (hybrid hyrax)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison between hyrax and hybrid hyrax
Number of subjects: 32
Study: 35632583

Group type: EXPERIMENTAL
Intervention: Advertising campaign for influenza vaccination using posters and pamphlets in GP waiting rooms
Number of subjects: 23024

Group type: COMPARATOR
Intervention: Control group of the initial RCT
Number of subjects: 23024
Study: 33198644

Group type: EXPERIMENTAL
Intervention: Suicide cases
Number of subjects: 242

Group type: COMPARATOR
Intervention: Matched living controls
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 242
Study: 35495371

Group type: EXPERIMENTAL
Intervention: Positive pressure (PEEP level of 5 CmH2o)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Negative pressure (suction pressure of 100 mmHg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Positive pressure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Negative pressure
Number of subjects: 100
Study: 32081514

Group type: EXPERIMENTAL
Intervention: International Society for Stem Cell Research booklet
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Stem Cell Network video
Number of subjects: 112

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 112
Study: 35681696

Group type: EXPERIMENTAL
Intervention: Personalised risk estimate calculated using the CanRisk risk prediction tool.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cancer risk estimates as per routine clinical practice.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalised risk estimate.
Number of subjects: 0
Study: 32056186

Group type: EXPERIMENTAL
Intervention: Definitive chemoradiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensity modulated radiotherapy
Number of subjects: 0
Study: 33506875

Group type: COMPARATOR
Intervention: Subcutaneous tocilizumab (s.c.-TCZ) 162 mg/dose administered weekly or every 2 weeks for sJIA and every 2 or 3 weeks for pJIA based on body weight.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Subcutaneous tocilizumab (s.c.-TCZ)
Number of subjects: 103
Study: 32366293

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) for 5 weeks during acute care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard hospital diet (SD)
Number of subjects: 60
Study: 35527114

Group type: EXPERIMENTAL
Intervention: 0.01% atropine combined with orthokeratology (OK)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Placebo solution combined with orthokeratology (OK)
Number of subjects: 62

Group type: COMPARATOR
Intervention: 0.01% atropine with spectacles
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo solution with spectacles
Number of subjects: 62
Study: 32940765

Group type: COMPARATOR
Intervention: Clotrimazole (CT) 100 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dequalinium chloride (DQC) 10 mg
Number of subjects: 150
Study: 36217643

Group type: EXPERIMENTAL
Intervention: SmearOFF as the final irrigant + 2% Chlorhexidine gel as intracanal medicament (n=14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 5.25% Sodium Hypochlorite (NaOCl) + Calcium Hydroxide (Ca(OH)2) as intracanal medicament (n=14)
Number of subjects: 28
Study: 34463425

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg
Number of subjects: 2233

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2233

Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 2233
Study: 34187137

Group type: EXPERIMENTAL
Intervention: Family Centered Empowerment Model (FCEM); 8 sessions over 2 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 35652260

Group type: EXPERIMENTAL
Intervention: Letrozole (LZ) 5 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 33271884

Group type: EXPERIMENTAL
Intervention: e-health intervention (computer-based prompts)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 35782695

Group type: EXPERIMENTAL
Intervention: Tensioning NM
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sliding NM
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham NM
Number of subjects: 90
Study: 35511686

Group type: EXPERIMENTAL
Intervention: Video instruction
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Instruction via images
Number of subjects: 54

Group type: COMPARATOR
Intervention: Written panel instructions
Number of subjects: 54
Study: 32991363

Group type: COMPARATOR
Intervention: 2D fluoroscopy
Number of subjects: 41

Group type: COMPARATOR
Intervention: 3D navigation
Number of subjects: 41
Study: 35917264

Group type: EXPERIMENTAL
Intervention: Long-pulsed 1,064-nm Nd:YAG laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Trichloroacetic acid (TCA) 20%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both modalities (Nd:YAG laser and TCA 20%)
Number of subjects: 20
Study: 34976331

Group type: EXPERIMENTAL
Intervention: Active initiation of secondary prevention therapy (aspirin, beta-blockers, statins, ACEI/ARBs)
Number of subjects: 1083

Group type: COMPARATOR
Intervention: Passive continuation of prior medication (aspirin, beta-blockers, statins)
Number of subjects: 1083
Study: 32652910

Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy (MMT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-drug users (N-MMT group)
Number of subjects: 80
Study: 36053844

Group type: EXPERIMENTAL
Intervention: Zoledronate
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study: 33581958

Group type: EXPERIMENTAL
Intervention: 3D modified digital surgical guide plates and preformed titanium plates (Group A)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Preformed titanium plates only (Group B)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional treatment (Group C)
Number of subjects: 22
Study: 35093230

Group type: EXPERIMENTAL
Intervention: Inactivated whole‐virion SARS‐CoV‐2 vaccine (CoronaVac)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33619579

Group type: EXPERIMENTAL
Intervention: LITE programme
Number of subjects: 61

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 61
Study: 32301590

Group type: EXPERIMENTAL
Intervention: Intraarticular Trans-capsaicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36431193

Group type: EXPERIMENTAL
Intervention: Diacutaneous fibrolysis (DF) added to pharmacological intervention, 3 sessions
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pharmacological intervention alone (standard care group)
Number of subjects: 82
Study: 35180137

Group type: EXPERIMENTAL
Intervention: Physician recommended school accommodations (≤90 days post-injury)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Physician recommended school accommodations
Number of subjects: 200
Study: 34733813

Group type: EXPERIMENTAL
Intervention: Yoga group (N = 49) attended a yoga course consisting of 10 sessions (1.5 h each) on a weekly basis
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (N = 33) did not receive any intervention
Number of subjects: 82
Study: 36003059

Group type: EXPERIMENTAL
Intervention: German condition (second language)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Spanish condition (first language)
Number of subjects: 32
Study: 33386289

Group type: EXPERIMENTAL
Intervention: Holmium laser en-bloc resection (HolERBT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional transurethral resection of bladder tumor (cTURBT)
Number of subjects: 100
Study: 34474033

Group type: EXPERIMENTAL
Intervention: MISA 1 cohort (2007-2009)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MISA 2 cohort (2019)
Number of subjects: 100
Study: 33878619

Group type: EXPERIMENTAL
Intervention: Robotic exoskeleton-assisted exercise rehabilitation (REAER)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional gait training (CGT)
Number of subjects: 10
Study: 32129196

Group type: EXPERIMENTAL
Intervention: Step-wise sodium profile and ultrafiltration (UF)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Linear sodium profile and ultrafiltration (UF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Routine method
Number of subjects: 32
Study: 35175967

Group type: EXPERIMENTAL
Intervention: HPV16+
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HPV18 or 18/45+
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Other genotypes+
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PD-L1 positive tumors (CPS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PD-L1 positive tumors (TPS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tumors with patterns B and C
Number of subjects: 120
Study: 33477648

Group type: EXPERIMENTAL
Intervention: Cistanche tubulosa (CT) extract for 12 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cistanche tubulosa (CT) extract
Number of subjects: 26
Study: 35305137

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC) diagnostics followed by a single operation with panendoscopy and incisional biopsy for confirmation of LBC result, then transoral tumor resection ± neck dissection and tracheostomy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Diagnostic panendoscopy with incisional biopsy followed by a second operation with transoral tumor resection ± neck dissection and tracheostomy
Number of subjects: 25
Study: 35427491

Group type: EXPERIMENTAL
Intervention: Vaccination on attendance (VoA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccination on diagnosis (VoD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccination according to risk (VaR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4CMenB under VaR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypothetical gonorrhoea vaccine
Number of subjects: 0
Study: 33615642

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 32243716

Group type: EXPERIMENTAL
Intervention: 10 mg of ketorolac tromethamine prior to local anaesthesia with 2% lignocaine and 1:80,000 adrenaline
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 10 mg of ketorolac tromethamine prior to local anaesthesia with 4% articaine and 1:100,000 adrenaline
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no ketorolac)
Number of subjects: 126
Study: 34998795

Group type: EXPERIMENTAL
Intervention: Gradient-boosting decision tree (GBDT) model
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Conventional Cox proportional hazard model
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Machine learning models (3 models including GBDT)
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Endoscopic and histologic findings
Number of subjects: 1099

Group type: EXPERIMENTAL
Intervention: Personalized cumulative incidence prediction curve
Number of subjects: 1099
Study: 32912759

Group type: EXPERIMENTAL
Intervention: Care bundle implementation (intervention group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Non-standardized care (control group)
Number of subjects: 110
Study: 34984933

Group type: EXPERIMENTAL
Intervention: Exposure to local Paralympic Games coverage information via e-mail
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group receiving no e-mails about coverage
Number of subjects: 119
Study: 32888192

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion (CII) of enoxaparin
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard subcutaneous bolus (SCB) of enoxaparin
Number of subjects: 38
Study: 35164586

Group type: EXPERIMENTAL
Intervention: Thematic framing with heterosexual male perpetrators
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Punishment preferences for heterosexual male perpetrators
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Punishment preferences for male or female homosexual perpetrators
Number of subjects: 750
Study: 32216731

Group type: EXPERIMENTAL
Intervention: Pelvic intensity-modulated radiation therapy (IMRT)
Number of subjects: 5289
Study: 32273209

Group type: EXPERIMENTAL
Intervention: CO2 laser microlaryngeal surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional microlaryngeal surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 80
Study: 36490309

Group type: EXPERIMENTAL
Intervention: metformin combined with neoadjuvant chemotherapy and trastuzumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: neoadjuvant chemotherapy and trastuzumab without metformin
Number of subjects: 0
Study: 33845173

Group type: EXPERIMENTAL
Intervention: tACS over prefrontal or somatosensory cortices at alpha or gamma frequencies
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham tACS
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Alpha tACS over somatosensory cortex
Number of subjects: 29
Study: 32729631

Group type: EXPERIMENTAL
Intervention: Pimavanserin (34 mg)
Number of subjects: 76
Study: 35273972

Group type: EXPERIMENTAL
Intervention: Alginate drink (one bottle twice a day for 8 weeks after A-FMT)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo (instead of alginate drink)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Alginate drink
Number of subjects: 2
Study: 33298145

Group type: EXPERIMENTAL
Intervention: Football training (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aerobic exercise training (n = 30)
Number of subjects: 60
Study: 34175217

Group type: EXPERIMENTAL
Intervention: Familias Unidas for Health and Wellness (FUHW)
Number of subjects: 280
Study: 32183874

Group type: EXPERIMENTAL
Intervention: Cognitive Occupation-Based programme (COB-MS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual, wait-list control group
Number of subjects: 120
Study: 35985975

Group type: EXPERIMENTAL
Intervention: Loop DJB‐SG
Number of subjects: 96

Group type: COMPARATOR
Intervention: Roux-en-Y DJB‐SG
Number of subjects: 96